sarpogrelate

This page covers all sarpogrelate drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting 5-hydroxytryptamine receptor 2A, 5-hydroxytryptamine receptor 2B, 5-hydroxytryptamine receptor 2C.

Targets

5-hydroxytryptamine receptor 2A, 5-hydroxytryptamine receptor 2B, 5-hydroxytryptamine receptor 2C

Phase 3 pipeline (1)

• Anplag · Hematology
  Anplag works by blocking the 5-hydroxytryptamine receptor 2A, which helps to relax blood vessels and improve blood flow.

Patent intelligence

• sarpogrelate patent landscape — aggregated cliff calendar, attackable patents, originator estates